News
ReNeuron's latest press releases
Preliminary Results for the Year Ended 31 March 2009 . 30/06/09
ReNeuron announces preliminary results for the Group for the year ended 31 March 2009.
Read articleReNeuron signs manufacturing contract to provide stem cells for stroke clinical trial. 09/06/09
Guildford, UK, 9 June 2009: ReNeuron Group plc (LSE: RENE.L) today announces that it has signed a contract with Angel Biotechnology Holdings plc (&…
Final closing of the placing and capitalisation of loan notes. 18/05/09
Guildford, UK, 18 May 2009: ReNeuron Group plc (LSE: RENE.L) announced on 12 March 2009 its intention to raise up to £3 million via a placing …
Regulatory Update. 14/05/09
Guildford, UK, 14 May 2009: ReNeuron Group plc (LSE: RENE.L) today provides a regulatory update regarding its ReN001 stem cell therapy for stroke. In …
Third closing of the placing. 14/05/09
Guildford, UK, 14 May 2009: ReNeuron Group plc (LSE: RENE.L) announced on 12 March 2009 its intention to raise up to £3 million via a placing of …
New data regarding ReNeuron's ReN001 stem cell line for stroke to be presented at US conference. 01/05/09
Guildford, UK, 1 May 2009: ReNeuron Group plc (LSE: RENE.L) today announces further data concerning the pre-clinical characterisation and mode of …
ReNeuron successfully automates its stem cell manufacturing process. 09/04/09
Guildford, UK, 9 April 2009: ReNeuron Group plc (LSE: RENE.L) today announces the publication of a paper in the journal Biotechnology Letters* …
Second closing of the placing. 07/04/09
Guildford, UK, 7 April 2009: ReNeuron Group plc (LSE: RENE.L) announced on 12 March 2009 its intention to raise up to £3 million via a placing …
1 2 3 4 5 6 7 8 9 10 11 >>If you would like to be alerted when a new press release is added, please click here to register with our Alerting Service.
Top of page